Related Experiment Video

Updated: Aug 8, 2026

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
10:25

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on: June 5, 2021

Immunofluorescence assay for serologic diagnosis of SARS

Paul K S Chan1, King-Cheung Ng, Rickjason C W Chan

  • 1Department of Microbiology, Faculty of Medicine, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, People's Republic of China. paulkschan@cuhk.edu.hk

Emerging Infectious Diseases
|April 28, 2004
PubMed

Insights

This study presents a highly accurate indirect immunofluorescence assay for detecting antibodies against the SARS-CoV virus. The assay demonstrated 100% sensitivity and specificity in identifying SARS-CoV infection through IgG antibody detection.

Area of Science:

  • Virology
  • Immunology
  • Diagnostic Assay Development

Background:

  • Severe Acute Respiratory Syndrome (SARS) is a significant global health concern.
  • Accurate diagnostic tools are crucial for managing SARS outbreaks.
  • Detecting specific antibodies like immunoglobulin G (IgG) is key to confirming infection.

Purpose of the Study:

  • To evaluate an indirect immunofluorescence assay (IFA) for detecting SARS-CoV IgG antibodies.
  • To determine the diagnostic accuracy of the IFA for SARS-CoV infection.

Main Methods:

  • Utilized an indirect immunofluorescence assay employing virus-infected cells.
  • Tested samples from confirmed SARS cases and control groups.
  • Measured anti-SARS-CoV IgG antibody titers.

Main Results:

  • All confirmed SARS cases showed seroconversion or a significant rise in IgG antibody titers.
  • No individuals in the control group tested positive for the antibody.
  • The assay achieved 100% sensitivity and 100% specificity.

Conclusions:

  • The indirect immunofluorescence assay is a reliable method for diagnosing SARS-CoV infection.
  • The assay can accurately ascertain the infection status by detecting specific IgG antibodies.
  • This diagnostic approach offers high precision for identifying past or present SARS-CoV exposure.

More Related Videos

A Rapid, Multiplex Dual Reporter IgG and IgM SARS-CoV-2 Neutralization Assay for a Multiplexed Bead-Based Flow Analysis System07:08

A Rapid, Multiplex Dual Reporter IgG and IgM SARS-CoV-2 Neutralization Assay for a Multiplexed Bead-Based Flow Analysis System

Published on: April 6, 2021

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-1908:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

Related Concept Videos

Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.
Immunofluorescence Microscopy01:12

Immunofluorescence Microscopy

A fluorescence microscope uses fluorescent chromophores called fluorochromes, which can absorb energy from a light source and then emit this energy as visible light. Fluorochromes include naturally fluorescent substances (such as chlorophylls) and fluorescent stains that are added to the specimen to create contrast. Dyes such as Texas red and FITC are examples of fluorochromes. Other examples include the nucleic acid dyes 4’,6’-diamidino-2-phenylindole (DAPI), and acridine orange.
The...